Luthra, AZB, Crawford, Platinum, Cravath, Covington advise on Mylan’s $800 million acquisition of Famy Care’s female health biz

Pallavi Saluja February 3 2015

US-based generic drugmaker Mylan Inc is acquiring the women's health business of Mumbai-based Famy Care for roughly $800 million (around Rs. 4,950 crore).

The acquisition is being made through its Indian unit, Mylan Laboratories Ltd, for $750 million in cash and an additional $50 million in contingent payments, reports Mint.

Luthra & . . .

You need to have an active subscription to view this content.